Abeona Therapeutics SVP sells $34,681 in company stock
On September 29, 2026, Brendan M. O'Malley, Senior Vice President and Chief Legal Officer at Abeona Therapeutics Inc., sold 6,727 shares of the company's common stock. The sale generated a total value of $34,681, with shares traded at prices between $5.1150 and $5.3000. O'Malley's transaction was primarily to satisfy tax obligations related to the vesting of restricted stock awards.
Following the sale, the company's stock price of $5.16 had decreased by nearly 7% over the past week. As a result of this transaction, O'Malley now holds 421,226 shares of Abeona Therapeutics common stock. An InvestingPro analysis suggests that the stock is currently undervalued based on Fair Value calculations. The platform also provides 11 additional ProTips for ABEO, including insights into the company's cash position and profitability outlook.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
